Association Between High-Deductible Health Plan Enrollment and Access to Care Among Patients Diagnosed with Type 2 Diabetes
AMCP Nexus
By: Anna Watzker, MHS, Pratik Pimple, PhD, Matthew Sussman, MA, Saurabh Ray, PhD
Publications
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Cardiovascular
By: Matthew Sussman, Manuela Di Fusco, Charles Y. Tao, Jennifer D. Guo, John A. Gillespie, Mauricio Ferri, Nicholas Adair, Matthew S. Cato, Ilnaz Shirkhorshidian & Geoffrey D. Barnes
Podium and Posters from ICPE 2021
ICPE All Access
By: Various Authors
Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review
Advances in Therapy
By: Matthew Sussman, Concetta Crivera, Jennifer Benner & Nicholas Adair
Podium and Poster from 2021 Virtual ISPOR
ISPOR 2021
By: Various Authors
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations
Clinical Drug Investigation
By: Nina Shah, Matthew Sussman, Concetta Crivera, Satish Valluri, Jennifer Benner & Sundar Jagannath
Virtual ISPOR Europe 2020 Publications
Virtual ISPOR Europe 2020
By: Various Authors
ICPE All Access Publications
ICPE All Access
By: Various Authors
Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders
Applied Health Economics Health Policy
By: Matthew Sussman, Jeffrey C Yu, Joseph Menzin
Estimated Lifetime Economic Burden of Type 1 Diabetes
Diabetes Technology & Therapeutics
By: Matthew Sussman, Jennifer Benner, Dr. Michael Haller, Dr. Marian Rewers, Dr. Robert Griffiths
Validation of Obesity Coding Among Newly Treated Nonvalvular Atrial Fibrillation Patient Using an Integrated Electronic Medical Record and Claims Database
Current Medical Research and Opinion
By: R Jain, A Watzker, X Luo, A Kang, C Baker
Economic Burden of Treatment Resistant Depression on the US Health Care System
Journal of Managed Care and Specialty Pharmacy
By: M Sussman, A O’Sullivan, A Shah, M Olfson, J Menzin
Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database
Leukemia and Lymphoma
By: J Shaw, C Harvey, C Richards, C Kim
Changes over time in treatment among patients with Rheumatoid Arthritis (RA) in Japan: Evidence from JMDC Inc. Database
Value in Health, ISPOR 2019
By: L Zhang, R Jain, C Richards, J Menzin
Real World Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Treating Patients with Atherosclerotic Cardiovascular Disease – an EMR Analysis of an Integrated Delivery Network
The American Journal of Cardiology
By: E Ramsaran, P Preusse, D Sundaresan, et al.
Referral Pathways in the Evaluation of Syncope
Circulation: Cardiovascular Quality and Outcomes
By: J Rogers, S Rosemas, J Sims, D Homsy, A Garman, C Richards
Travel Burden Associated with Rare Cancers: The Example of Merkel Cell Carcinoma
Cancer Medicine
By: R Jain, J Menzin, K Lachance, P McBee, H Phatak
Treatment, HSCT Patterns, and Survival of Elderly Diffuse Large B-Cell Lymphoma Patients in the SEER-Medicare Linked Database
Blood, 2018.
By: J Shaw, L Johns, C Harvey, C Richards and C Kim
Pregnancy rates and outcomes in women with and without MS in the United States
Neurology
By: MK Houtchens, NC Edwards, G Schneider, K Stern, AL Phillips
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Cephalalgia
By: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin
Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder
Value in Health, ISPOR 2018
By: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson
Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.
Circulation
By: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip
Comorbidity in US patients with multiple sclerosis
Patient Related Outcome Measures
By: N Edwards, M Munsell, J Menzin, A Phillips
Development and validation of a claims-based measure as an indicator for disease severity in patients with multiple sclerosis treated with disease-modifying drugs
BMC Neurology
By: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips
Impact of Subsequent Metastases on Costs and Medical Resource Use in Prostate Cancer Patients Initially Diagnosed with Localized Disease
Cancer (American Cancer Society Journal)
By: Tracy Li, PhD; Neal Shore, MD; Maneesha Mehra, PhD; Mary Todd, MD; Ryan Saadi, MD; Gaetan Leblay, MBA; Jyoti Aggarwal, MHS; Robert Griffiths, MS, ScD
Epidemiological trends of Carbapenem ResistantEnterobacteriaceae (CRE) in the US from 2009-2015
SHEA Spring 2017 Conference
By: M Zilberberg, G Schneider, and H Patel
How are quality of life and work productivity associated with living longer with HER2+ metastatic breast cancer?
Journal of Clinical Oncology
By: P Bajaj, M Sussman, J Yu, C Reyes, A Stein, C Lai, M Mayer, S Hurvitz, D Tripathy
Medical Resource Use and Cost Consequences of Hospitalization for Repositioning, Repair, or Removal of Implantable Cardioverter Defibrillator Transvenous Leads
Value in Health 20(5):A249
By: R Griffiths, C Jacobsen, K Stern, J Menzin, S Amorosi
Excess Costs Associated with Central Sleep Apnea in the Elderly
Value in Health 19 (2016), A347 – A766
By: M Sussman, P McBee, J Menzin.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization
